Amneal Receives U.S. FDA Approval for Iohexol Injection

Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare’s Omnipaque® (iohexol) injection. Amneal expects to launch the product in the first quarter of 2026. Iohexol is a radiographic contrast agent indicated […]

PDM Healthcare Announces Expansion in Consumer Product Portfolio

PDM Healthcare has partnered with Perrigo Company, plc, a leading manufacturer of consumer self-care products, to bring a complete product portfolio of OTC health and wellness products to our customers!  The discounted pricing available through the PDM – Perrigo Channel Partner offers cost-effective pricing on several hundred SKUs of cough, cold, analgesic, gastrointestinal, smoking cessation, […]

Introducing Alpha Labs: Driving AI and Automation Innovation at SoftWriters

SoftWriters has officially launched Alpha Labs, a dedicated cross-functional innovation team charged with charting the optimal path to unlock the full potential of AI and automation across our product suite. This initiative represents a major step forward in the ongoing effort to reimagine how technology can transform long-term care pharmacy operations. The Alpha Labs team is uniquely positioned to […]

DHL Supply Chain Completes Acquisition of SDS Rx

Acquisition enables end-to-end life science and health care logistics capabilities DHL Supply Chain, North America’s leading contract logistics provider, announced the successful completion of its acquisition of SDS Rx, a specialized provider of final-mile delivery and healthcare transportation services. The transaction marks a significant milestone in DHL’s strategic expansion within the life sciences and healthcare […]

Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables

Launches as Top 15 U.S. Generic Drug Manufacturer, Largest U.S. Producer of Active Pharmaceutical Ingredients and Premier U.S. Producer of Sterile Injectables Poised for Long-Term Growth with the Scale, Capabilities and Focus to Meet Global Demand for Essential Medicines Experienced Leadership Team with Deep Expertise Across Product Development, Manufacturing, Supply Chain, Quality, Compliance and Business […]

Parasol Medical Named One of Chicago’s Most Innovative Companies by Crain’s

Parasol Medical, a leader in healthcare innovation, has been recognized by Crain’s Chicago Business as one of the region’s most innovative companies for 2025. The honor highlights Parasol’s groundbreaking work in patient safety and infection prevention technologies. Founded by Mike Kilcran, Parasol Medical has developed a suite of patented solutions aimed at improving care in hospitals and […]

Swisslog Healthcare Launches PillPick Octave, Advancing Medication Safety

Swisslog Healthcare, a pharmacy automation solutions provider, announces the launch of PillPick Octave, its newest model of the PillPick automated unit dose system. This new iteration offers new functionality and advances medication safety of patient specific medications. Additionally, the PillPick Octave gives customers new choices for more ecofriendly packaging. Read More >

BOC Honors Dexter Moon as 2025 Certificant of the Year

The Board of Certification/Accreditation (BOC) is proud to announce Dexter Moon, CDME, chief operating officer of Project MEND, as the recipient of the organization’s 2025 Certificant of the Year Award. Moon is being honored for his exceptional leadership and commitment to service, innovation and outreach in the field of durable medical equipment (DME). A BOC […]

Endo Launches First and Only Generic Version of RAVICTI® (glycerol phenylbutyrate) Oral Liquid in the United States

Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today the launch of a generic version of Amgen’s RAVICTI® (glycerol phenylbutyrate), 1.1 gm/mL oral liquid, following final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application. Endo’s glycerol phenylbutyrate is the first and currently the only FDA-approved generic version of RAVICTI® available in the U.S. […]

SoftWriters Welcomes Jeff Hlozek as Chief Revenue Officer

We’re thrilled to announce that Jeff Hlozek has joined SoftWriters as our Chief Revenue Officer (CRO). In this new role, Jeff will lead our Sales and Marketing teams to strengthen alignment, accelerate growth, and continue driving innovation across our product suite. Jeff brings over 25 years of leadership experience in healthcare technology, software, and innovation-driven organizations. His background reflects a deep […]